Toll Free: 1-888-928-9744

Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017

Published: Aug 8, 2017 | Pages: 118 | Publisher: QYResearch | Industry: Medical Devices | Report Format: Electronic (PDF)

In this report, the Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices market competition by top manufacturers/players, with Benign Prostatic Hyperplasia (BPH) Treatment Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Endo International (US)
    Karl Storz (Germany)
    Medtronic (US)
    Siemens (Germany)
    Lumenis (Israel)
    Olympus (Japan)
    Urologix (US)
    NeoTract (US)
    Boston Scientific (US)
    Urotech (Germany)
    Toshiba (Japan)
    Baxter International (US)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Laser Based Procedure
    Other Energy Based Procedure

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for each application, includin
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2017
1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Overview
    1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    1.2 Classification of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Product Category
        1.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Laser Based Procedure
        1.2.4 Other Energy Based Procedure
    1.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Application/End Users
        1.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Specialty Clinics
        1.3.5 Other
    1.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Region
        1.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Treatment Devices (2012-2022)
        1.5.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Type
        2.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume) by Application
    2.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Region
        2.4.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Region (2012-2017)

3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    3.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        3.1.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        3.1.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    3.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    3.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    4.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        4.1.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    4.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    4.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    5.1 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        5.1.1 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    5.2 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    5.3 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

6 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    6.1 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        6.1.1 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    6.2 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    6.3 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    7.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        7.1.1 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        7.1.3 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    7.2 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    7.3 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

8 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    8.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        8.1.1 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    8.2 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    8.3 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

9 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price)
    9.1 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value (2012-2017)
        9.1.1 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price Trend (2012-2017)
    9.2 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Type
    9.3 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share by Application

10 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Players/Suppliers Profiles and Sales Data
    10.1 Endo International (US)
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Karl Storz (Germany)
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Medtronic (US)
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Siemens (Germany)
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Lumenis (Israel)
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Olympus (Japan)
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Urologix (US)
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 NeoTract (US)
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Boston Scientific (US)
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Urotech (Germany)
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Toshiba (Japan)
    10.12 Baxter International (US)

11 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
    11.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2017-2022)
    15.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (Product Category) in 2016
    Figure Laser Based Procedure Product Picture
    Figure Other Energy Based Procedure Product Picture
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application (2012-2022)
    Figure Asia-Pacific Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Application in 2016
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Ambulatory Surgical Centers Examples
    Table Key Downstream Customer in Ambulatory Surgical Centers
    Figure Specialty Clinics Examples
    Table Key Downstream Customer in Specialty Clinics
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Million USD) by Region (2012-2022)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate (2012-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Sales Volume (K Units)(2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) of Key Players/Suppliers (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Players/Suppliers
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Major Players Product Revenue (Million USD) 2012-2017
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
    Figure 2017 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Players
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Type (2012-2017)
    Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Type (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate by Type (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Market Share by Region (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Region (2012-2017)
    Figure Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2016
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region in 2016
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Market Share by Application (2012-2017)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share (%) by Application (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2012-2017)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Application (2012-2017)
    Table India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price (USD/Unit) Trend (2012-2017)
    Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Type (2012-2017)
    Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type (2012-2017)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Type in 2016
    Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) by Applications (2012-2017)
    Table Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application (2012-2017)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share by Application in 2016
    Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2012-2017)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share in Asia-Pacific (2012-2017)
    Figure Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share in Asia-Pacific (2012-2017)
    Table Toshiba (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Baxter International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price (USD/Unit) Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    Figure Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    Figure Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
    Table Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers in 2016
    Table Major Buyers of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    Table Distributors/Traders List
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) and Trend Forecast (2017-2022)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume (K Units) Forecast by Region (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume Market Share Forecast by Region in 2022
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Region (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region in 2022
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Type (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) Forecast by Type (2017-2022)
    Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2017-2022)
    Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global polymethyl methacrylate (PMMA) market size is likely to be valued at USD 11.65 billion by 2022; as per a new research report by Radiant Insights, Inc. Increasing spending on advertising & marketing for building strong brand equity and product

Read More...

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify